Key facts
- Doncasters is targeting a valuation of up to $4.43 billion in its U.S. IPO.
- Doncasters plans to raise up to $746.7 million in its U.S. IPO.
- Doncasters is a manufacturer of aerospace and industrial parts.
- Doncasters plans to list on the New York Stock Exchange.
- Doncasters will trade under the ticker symbol "DPC".
- Foundation Healthcare is preparing to submit its IPO prospectus in Singapore.
- Foundation Healthcare is expected to file its prospectus within the next few days.
Doncasters, a company specializing in the manufacture of aerospace and industrial parts, is pursuing a U.S. initial public offering (IPO) with a target valuation of up to $4.43 billion. The company aims to raise a maximum of $746.7 million through this offering. Doncasters intends to list its shares on the New York Stock Exchange, where it will trade under the ticker symbol "DPC".
In a separate development, Foundation Healthcare is making preparations to submit its IPO prospectus in Singapore. The company is expected to file this crucial document within the next few days, signaling a step forward in its public offering plans. The specific details of Foundation Healthcare's IPO, including valuation and fundraising targets, are not provided in the available information.